Clinical Manifestations.

Alzheimers Dement

University of Virginia, Charlottesville, VA, USA.

Published: December 2024

Background: There is mounting evidence that difficulties with sleep including insomnia, sleep quality, and sleep fragmentation contribute to Alzheimer's disease risk including formation of beta-amyloid. Disrupted sleep is common in people with dementia (PWD). Primary unpaid caregivers (CGs) of PWD may also have disrupted sleep as a result of their caregiving roles. It is clear that CGs experience CG burden, stress and depression. The interplay of CG-PWD dyads and the impact of behavior, cognition and sleep in the PWD on the CG are relatively understudied.

Method: Eight dyads consisting of individuals diagnosed with Alzheimer's Disease (AD) (PWD) and their CGs were recruited from the Virginia Alzheimer's Disease Center (VADC) Clinical Cohort. Diagnosis of AD in the VADC cohort was made by team consensus using neuroimaging, biomarker, neurological and neuropsychological data. All participants had wrist actigraphy measured for 14 days and overnight polysomnography (PSG) done in a sleep lab. Dyad members were in separate rooms during PSG. Dyads members independently completed the Montreal Cognitive Assessment 12, the Geriatric Depression Scale 13, Epworth Sleepiness Scale 14, and the Quality of Life in Alzheimer's Disease scale 15 (QOL). CGs only completed the Preparedness for Caregiving Scale 16 and the Zarit Burden Interview and the Neuropsychiatric inventory.

Result: Neither activity nor rest over 14 days differed within dyads. Relative to PWD, CGs experienced shorter total sleep, lower sleep efficiency, and longer sleep onset. CG and PWD depression and QOL did not differ between dyad members. Importantly, poorer CG sleep was associated with higher CG burden and greater PWD neuropsychiatric symptoms but not with degree of cognitive impairment in the PWD.

Conclusion: Results suggest that sleep in CGs can be more impaired than the PWDs they are caring for even when sleeping separately. Importantly, behavioral disturbance may be more problematic than PWD cognitive impairment level in CG sleep. These may have implications for ability to care for the PWD potentially impacting nursing home placement. Furthermore, PWD sleep characteristics may impact longer-term CG health and well-being.

Download full-text PDF

Source
http://dx.doi.org/10.1002/alz.091005DOI Listing

Publication Analysis

Top Keywords

alzheimer's disease
16
sleep
14
pwd
10
disrupted sleep
8
pwd cgs
8
dyad members
8
cognitive impairment
8
cgs
6
clinical manifestations
4
manifestations background
4

Similar Publications

β-secretase (BACE1) is instrumental in amyloid-β (Aβ) production, with overexpression noted in Alzheimer's disease (AD) neuropathology. The interaction of Aβ with the receptor for advanced glycation endproducts (RAGE) facilitates cerebral uptake of Aβ and exacerbates its neurotoxicity and neuroinflammation, further augmenting BACE1 expression. Given the limitations of previous BACE1 inhibition efforts, the study explores reducing BACE1 expression to mitigate AD pathology.

View Article and Find Full Text PDF

Dementia refers to an umbrella phenotype of many different underlying pathologies with Alzheimer's disease (AD) being the most common type. Neuropathological examination remains the gold standard for accurate AD diagnosis, however, most that we know about AD genetics is based on Genome-Wide Association Studies (GWAS) of clinically defined AD. Such studies have identified multiple AD susceptibility variants with a significant portion of the heritability unexplained and highlighting the phenotypic and genetic heterogeneity of the clinically defined entity.

View Article and Find Full Text PDF

Amyloidogenic protein aggregation is a pathological hallmark of Alzheimer's Disease (AD). As such, this critical feature of the disease has been instrumental in guiding research on the mechanistic basis of disease, diagnostic biomarkers and preventative and therapeutic treatments. Here we review identified molecular triggers and modulators of aggregation for two of the proteins associated with AD: amyloid beta and tau.

View Article and Find Full Text PDF

Background: Certain peripheral proteins are believed to be involved in the development of Alzheimer's disease (AD), but the roles of other new protein biomarkers are still unclear. Current treatments aim to manage symptoms, but they are not effective in stopping the progression of the disease. New drug targets are needed to prevent Alzheimer's disease.

View Article and Find Full Text PDF

The Trail of axonal protein Synthesis: Origins and current functional Landscapes.

Neuroscience

January 2025

Departamento de Genómica, Instituto de Investigaciones Biológicas Clemente Estable, MEC, Av. Italia 3318, Montevideo, CP 11600, Uruguay; Departamento de Biología Celular y Molecular, Facultad de Ciencias, Universidad de la República, Iguá, Montevideo, 4225, CP 11400, Uruguay. Electronic address:

Local protein synthesis (LPS) in axons is now recognized as a physiological process, participating both in the maintenance of axonal function and diverse plastic phenomena. In the last decades of the 20th century, the existence and function of axonal LPS were topics of significant debate. Very early, axonal LPS was thought not to occur at all and was later accepted to play roles only during development or in response to specific conditions.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!